New DNA test could speed up brain infection diagnosis
NCT ID NCT07435649
First seen Jun 26, 2026 · Last updated Jul 17, 2026 · Updated 3 times
Summary
This study is testing a new DNA-based test called Delve Detect CSF that looks for germs in spinal fluid. The goal is to see if using this test early, instead of as a last resort, helps doctors diagnose brain infections faster. About 400 people with suspected brain infections will take part, and their results will be compared to standard tests.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Delve Detect CSF mNGS Test (a DNA-based diagnostic test)
- What this could lead to
- If successful, this test could help doctors diagnose brain infections faster and more accurately, potentially leading to better treatment outcomes.
- What could go wrong
- This is an early study with 400 participants, and the test may not prove more effective than current methods. It also requires a spinal tap, which carries some risk.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CENTRAL NERVOUS SYSTEM INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Emory University Hospital
RECRUITINGAtlanta, Georgia, 30322, United States
-
Lahey Hospital & Medical Center
NOT_YET_RECRUITINGBurlington, Massachusetts, 01805, United States
-
University of California at San Francisco at Zuckerberg San Francisco General
NOT_YET_RECRUITINGSan Francisco, California, 94110, United States
-
Vanderbilt University Medical Center
RECRUITINGNashville, Tennessee, 37232, United States